Ratos's acquisition of 78% of Perlos Healthcare has today proceeded to the next stage, as Ratos have signed a definite sale and purchase agreement with all parties involved. The closing of the deal is expected to take place by the end of this year after the approval of the competition authorities has been received and other closing conditions of the transaction have been fulfilled.
The cash and debt free purchase price of Perlos's healthcare business by the new company is approximately EUR 67m. The purchase price will be paid in cash.
Ratos will make a maximum of EUR 30.4m equity investment in the newly formed holding company. Perlos Healthcare business unit's acting management will acquire approximately 2% and Perlos OY will hold on to an ownership stake of 20%.
The net sales of Perlos Healthcare business unit amounted to EUR 52.6m in 2005.
For further information, please contact:
Arne Karlsson, CEO Ratos, +46 8 700 17 00
Anna-Karin Celsing, Head of Corporate Communications Ratos, +46 70 399 62 39